Therapeutic targeting of hepatocellular carcinoma cells with antrocinol, a novel, dual-specificity, small-molecule inhibitor of the KRAS and ERK oncogenic signaling pathways.
暂无分享，去创建一个
David T. W. Tzeng | Y. Tzeng | A. Wu | Vijesh Kumar Yadav | C. Yeh | Jian-xian Gong | S. A. Setiawan | Pei‐Wei Weng | Pei-Wei Weng | Chia-Hung Hsu | Ming‐Yao Chen | Zhen Yang